australian healthcare

We believe lacklustre revenue growth and lumpy profitability mask the potential of SDI Limited’s post-COVID strategic shift

There is much more to come from Neuren. Following two years of substantial progress, we see significant upside from current levels.

There are only two states in software according to Pro Medicus CEO Dr Sam Hupert: "quick or dead". And Hupert doesn't much care to be dead.

Today's share price action certainly would suggest so.

Just because CSL hadn’t factored in financial benefit from CSL112, it doesn’t mean the market hadn’t.

The -32% decline in the share price of Australia's number three Large Cap has brought out the biases and prejudices in all of us

Rising bond yields and higher interest rate expectations has not been a good backdrop for stocks, but these three stocks are positive.

Morgan Stanley released its Post-result and FY24 Outlook for Australian Healthcare with a number of changes.

Profits may be up at Ramsay Health Care but the final dividend dropped by nearly 50%. In this interview, CEO Craig McNally shares why.

IML's Hugh Giddy bought more of this stock a little over a year ago, and he has no intentions of selling after today's results.